article thumbnail

No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge

Bill of Health

An estimated 500,000 patents were pledged under the Open COVID Pledge, with over a million more pledged under a similar Japanese effort. Like the Open COVID Pledge before it, Moderna’s pledge expressly states that it is valid only “ while the pandemic continues. Pfizer made such a vaccine. Moderna’s Pledge.

article thumbnail

Biotech Companies Are Opening Manufacturing Sites in Africa: Will This Help Vaccine Equity?

Bill of Health

Two pharmaceutical giants of the pandemic, Moderna and BioNTech, are taking steps for increasing the manufacturing capacity for the COVID-19 vaccine in Africa. Last March, Moderna announced its plan to set up a manufacturing facility in Kenya to produce messenger RNA (mRNA) vaccines, including COVID-19 shots.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

COVID ‘Compromise’ on International IP Underscores Need for New Approach

Bill of Health

Current vaccine and treatment inequity was not inevitable. Early on in the pandemic, the World Health Organization (WHO) proposed IP owners voluntarily license IP to others to ensure affordable COVID treatments. Existing international and domestic IP rules allow IP owners to voluntarily share their IP rights.

COVID-19 313
article thumbnail

Vaccine credentials enabling wider progress on public health interoperability

Healthcare It News

They'll explain how it's now positioned to move beyond mere immunization status and toward a larger approach to interoperable health records. And they'll show how, through an upcoming collaboration with the World Health Organization and the G20, those advancements can soon be expanding globally.

article thumbnail

Data Lights the Path Toward Ethical COVID-19 Vaccination Distribution

Healthcare IT Today

The following is a guest article by Kurt Waltenbaugh, CEO at Carrot Health.

article thumbnail

Moderna’s U.K. Vaccine Patent Pledge Cut Short by Boilerplate

Bill of Health

As I previously discussed in October of 2020, Moderna pledged not to enforce its patents against makers of COVID-19 vaccines during the pandemic. Then, in 2022, Moderna sued competing vaccine makers Pfizer and BioNTech.

article thumbnail

Using Contracts to Lessen Inequities in Access to Medicines in Pandemics and Epidemics

Bill of Health

Consider, for instance, the case of COVID-19 vaccines. Even those relying on a new type of vaccine technology, such as mRNA vaccines , resulted from well over a decade of R&D in mRNA vaccinology and used vaccine components that were developed well before the COVID-19 pandemic began.